Literature DB >> 6319426

1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.

D J Mangelsdorf, H P Koeffler, C A Donaldson, J W Pike, M R Haussler.   

Abstract

The human-derived promyelocytic leukemia cell line, HL-60, is known to differentiate into mature myeloid cells in the presence of 1,25-dihydroxyvitamin D3 (1,25[OH]2D3). We investigated differentiation by monitoring 1,25(OH)2D3-exposed HL-60 cells for phagocytic activity, ability to reduce nitroblue tetrazolium, binding of the chemotaxin N-formyl-methionyl-leucyl-[3H]phenylalanine, development of nonspecific acid esterase activity, and morphological maturation of Wright-Giemsa-stained cells. 1,25(OH)2D3 concentrations as low as 10(-10) M caused significant development of phagocytosis, nitroblue tetrazolium reduction, and the emergence of differentiated myeloid cells that had morphological characteristics of both metamyelocytes and monocytes. These cells were conclusively identified as monocytes/macrophages based upon their adherence to the plastic flasks and their content of the macrophage-characteristic nonspecific acid esterase enzyme. The estimated ED50 for 1,25(OH)2D3-induced differentiation based upon nitroblue tetrazolium reduction and N-formyl-methionyl-leucyl-[3H]phenylalanine binding was 5.7 X 10(-9) M. HL-60 cells exhibited a complex growth response with various levels of 1,25(OH)2D3: less than or equal to 10(-10) M had no detectable effect, 10(-9) M stimulated growth, and greater than or equal to 10(-8) M sharply inhibited proliferation. We also detected and quantitated the specific receptor for 1,25(OH)2D3 in HL-60 and HL-60 Blast, a sub-clone resistant to the growth and differentiation effects of 1,25(OH)2D3. The receptor in both lines was characterized as a DNA-binding protein that migrated at 3.3S on high-salt sucrose gradients. Unequivocal identification was provided by selective dissociation of the 1,25(OH)2D3-receptor complex with the mercurial reagent, p-chloromercuribenzenesulfonic acid, and by a shift in its sedimentation position upon complexing with anti-receptor monoclonal antibody. On the basis of labeling of whole cells with 1,25(OH)2[3H]D3 in culture, we found that HL-60 contains approximately 4,000 1,25(OH)2D3 receptor molecules per cell, while the nonresponsive HL-60 Blast is endowed with approximately 8% of that number. The concentration of 1,25(OH)2D3 (5 X 10(-9) M) in complete culture medium, which facilitates the saturation of receptors in HL-60 cells, is virtually identical to the ED50 for the sterol's induction of differentiation. This correspondence, plus the resistance of the relatively receptor-poor HL-60 Blast, indicates that 1,25(OH)2D3-induced differentiation of HL-60 cells to monocytes/macrophages is occurring via receptor-mediated events.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319426      PMCID: PMC2113084          DOI: 10.1083/jcb.98.2.391

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  42 in total

1.  A specific high-affinity binding macromolecule for 1,25-dihydroxyvitamin D3 in fetal bone.

Authors:  B E Kream; M Jose; S Yamada; H F DeLuca
Journal:  Science       Date:  1977-09-09       Impact factor: 47.728

2.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.

Authors:  S J Collins; R C Gallo; R E Gallagher
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

Review 3.  Basic and clinical concepts related to vitamin D metabolism and action (second of two parts).

Authors:  M R Haussler; T A McCain
Journal:  N Engl J Med       Date:  1977-11-10       Impact factor: 91.245

4.  A simple microscopic method for identifying and quantitating phagocytic cells in vitro.

Authors:  J Patterson-Delafield; R I Lehrer
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

5.  Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid.

Authors:  W E Stumpf; M Sar; F A Reid; Y Tanaka; H F DeLuca
Journal:  Science       Date:  1979-12-07       Impact factor: 47.728

6.  Monocyte function in man.

Authors:  M C Territo; M J Cline
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

7.  Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion.

Authors:  J Lotem; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

8.  Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.

Authors:  S J Collins; F W Ruscetti; R E Gallagher; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

9.  Association of 1,25-dihydroxyvitamin D3 with cultured 3T6 mouse fibroblasts. Cellular uptake and receptor-mediated migration to the nucleus.

Authors:  J W Pike; M R Haussler
Journal:  J Biol Chem       Date:  1983-07-25       Impact factor: 5.157

10.  Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.

Authors:  L T Williams; R Snyderman; M C Pike; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

View more
  70 in total

Review 1.  Molecular nature of the vitamin D receptor and its role in regulation of gene expression.

Authors:  P W Jurutka; G K Whitfield; J C Hsieh; P D Thompson; C A Haussler; M R Haussler
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells.

Authors:  T Mitsuhashi; R C Morris; H E Ives
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  1,25-Dihydroxyvitamin D3 and its analogues inhibit acute myelogenous leukemia progenitor proliferation by suppressing interleukin-1beta production.

Authors:  S Peleg; H Qiu; S Reddy; D Harris; Q Van; E H Estey; M Talpaz; Z Estrov
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

4.  1,25-Dihydroxy vitamin D2 induces leukemia cell differentiation.

Authors:  A Yen; J Blue; M Forbes
Journal:  In Vitro Cell Dev Biol       Date:  1991-07

5.  Induction of matrix Gla protein synthesis during prolonged 1,25-dihydroxyvitamin D3 treatment of osteosarcoma cells.

Authors:  J D Fraser; P A Price
Journal:  Calcif Tissue Int       Date:  1990-04       Impact factor: 4.333

6.  Normal bone marrow adherent cell-conditioned medium corrects the impaired differentiation of cultured mononuclear phagocytes from vitamin D-deficient rats.

Authors:  T Nakamura; K Araki; S Kanda; K Kurisu
Journal:  Calcif Tissue Int       Date:  1986-01       Impact factor: 4.333

Review 7.  Vitamin D-endocrine system.

Authors:  N H Bell
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

8.  1,25(OH)2D3 receptor regulation and 1,25(OH)2D3 effects in primary cultures of growth cartilage cells of the rat.

Authors:  G Klaus; J Merke; H Eing; U Hügel; P Milde; H Reichel; E Ritz; O Mehls
Journal:  Calcif Tissue Int       Date:  1991-11       Impact factor: 4.333

9.  Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line.

Authors:  M G Thomas; S Tebbutt; R C Williamson
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

10.  Differences in expression of transcription factor AP-1 in human promyelocytic HL-60 cells during differentiation towards macrophages versus granulocytes.

Authors:  F Mollinedo; C Gajate; A Tugores; I Flores; J R Naranjo
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.